A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss

OBJECTIVE: This study aims to assess the efficacy and safety of Gelesis100, a novel, nonsystemic, superabsorbent hydrogel to treat overweight or obesity. METHODS: The Gelesis Loss Of Weight (GLOW) study was a 24‐week, multicenter, randomized, double‐blind, placebo‐controlled study in patients with B...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Obesity (Silver Spring)
Egile Nagusiak: Greenway, Frank L., Aronne, Louis J., Raben, Anne, Astrup, Arne, Apovian, Caroline M., Hill, James O., Kaplan, Lee M., Fujioka, Ken, Matejkova, Erika, Svacina, Stepan, Luzi, Livio, Gnessi, Lucio, Navas‐Carretero, Santiago, Alfredo Martinez, J., Still, Christopher D., Sannino, Alessandro, Saponaro, Cosimo, Demitri, Christian, Urban, Lorien E., Leider, Harry, Chiquette, Elaine, Ron, Eyal S., Zohar, Yishai, Heshmati, Hassan M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587502/
https://ncbi.nlm.nih.gov/pubmed/30421844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.22347
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak